Johnson & Johnson (NYSE:JNJ) currently has a daily average trading volume of 9.68M but it saw 7032225 shares traded in last market. With a market cap of 368.56B USD, the company’s current market price of $153.18 came falling about -0.31 while comparing to the previous closing price of $153.66. In past 52 weeks, the stock remained buoying in the range of price level as high as $169.99 and as low as $140.68.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Leerink Partners which downgraded the stock as “Market Perform” in its note to investors issued on May 13, 2025, recommending a price target of $153 for it. Wolfe Research issued its recommendations for the stock as it initiated the price target for the stock is $190.
Over the week, JNJ’s stock price is moving 4.66% up while it is -2.90% when we observe its performance for the past one month. Year-to-date it is 5.92% up and over the past year, the stock is showing a downside performance of -0.94%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 2.68 while estimate for next year EPS is 10.61. In next quarter, company is expected to be making quarterly sales of $23.1B as analysts are expecting the sales for current fiscal year at $91.3B and seeing the company making $95.03B in sales next year. Moreover, analysts are in estimates of $22.85B for current-quarter revenue.
Currently, Johnson & Johnson’s total number of outstanding shares is 2.41B with 0.06% of that held by the insiders while 74.03% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 18.73% and return on equity (ROE) at 29.45%. It has a price to earnings ratio (P/E ratio) of 17.03 while having a 13.80 of forward P/E ratio. Stock’s beta reads 0.41. Stock has a price to book (P/B) ratio of 4.72 while price to sale or P/S ratio amounts to 4.13. Its return on asset (ROA) is 11.93% on average.
